awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q40236553-986B7864-2CDC-49C8-85CF-FAC82A687576
Q40236553-986B7864-2CDC-49C8-85CF-FAC82A687576
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40236553-986B7864-2CDC-49C8-85CF-FAC82A687576
Successful Management of Decitabine prior to Full-Dose Idarubicin and Cytarabine in the Treatment of Refractory/Recurrent Acute Myeloid Leukemia.
P2860
Q40236553-986B7864-2CDC-49C8-85CF-FAC82A687576
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40236553-986B7864-2CDC-49C8-85CF-FAC82A687576
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c4ce9482f10ac8280b638949b4da0be20f431906
P2860
DECIDER: prospective randomized multicenter phase II trial of low-dose decitabine (DAC) administered alone or in combination with the histone deacetylase inhibitor valproic acid (VPA) and all-trans retinoic acid (ATRA) in patients >60 years with acu